Inventor · disambiguated record
Matthew G. Beaver
Also filed as: BEAVER MATTHEW G · Beaver Matthew
4 granted patents·4 pending applications·0 citations·filing 2017–2025
55Inventor score
Files withAMGEN INC8
Top patents by PatentIndex Score
8 records- 0181US2025388579A1Synthesis of kras g12c inhibitor compoundAMGEN INC·Filed 2025·Application pending·0 cites
- 0279US2025179068A1Synthesis of kras g12c inhibitor compoundAMGEN INC·Filed 2024·Application pending·0 cites
- 0370US12466825B2Synthesis of KRAS G12C inhibitor compoundAMGEN INC·Filed 2020·Granted Nov 11, 2025·0 cites·42 claims
- 0461US2025122197A1Process for racemizing and isolating atropisomers of 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dioneAMGEN INC·Filed 2024·Application pending·0 cites
- 0556US12441741B2Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediatesAMGEN INC·Filed 2021·Granted Oct 14, 2025·0 cites·62 claims
- 0656US2023391771A1Process for racemizing and isolating atropisomers of 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dioneAMGEN INC·Filed 2021·Application pending·0 cites
- 0747US12351555B2Process for synthesizing apremilastAMGEN INC·Filed 2022·Granted Jul 8, 2025·0 cites·31 claims
- 0838US11708341B2Synthesis of (S)-2-amino-4-methyl-((R)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereofAMGEN INC·Filed 2017·Granted Jul 25, 2023·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Matthew G. Beaver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →